Search results for "rex"

showing 10 items of 701 documents

Modulation of oestrogen excretion profiles by adjuvant chemotherapy in pre- and postmenopausal breast cancer.

1985

Modulation of steroid status by conventional chemotherapy was studied in 31 breast cancer patients receiving CMF and in 31 age-matched breast cancer patients without any therapy, taken as controls. This was achieved through the study of oestrogen excretion profiles using previously identified parameters and referring not only to classical but also to the “other”, namely catechol and unusual, oestrogen metabolites. After CMF treatment the premenopausal patients exhibit a modified excretion pattern, mainly concerning a marked and significant reduction of classical oestrogens, as shown by pattern indices. Because there is evidence that oestriol metabolism is not markedly affected by CMF treatm…

Adultmedicine.medical_specialtyTime FactorschlormethineAdjuvant chemotherapymedicine.medical_treatmentBreast NeoplasmsBiochemistryestriolGas Chromatography-Mass SpectrometrySteroidExcretionEndocrinologyBreast cancerInternal medicineestradiolAntineoplastic Combined Chemotherapy ProtocolsmedicineestrogenHumansStage (cooking)CyclophosphamideChromatography High Pressure LiquidAgedbusiness.industryEstrogensMetabolismMiddle Agedmedicine.diseaseestroneEstrogens CatecholEndocrinologyMethotrexateMetabolic rateAdrenal CortexFemaleFluorouracilMenopausebusinessAfter treatmentJournal of steroid biochemistry
researchProduct

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Inn…

2007

To evaluate in a prospective multicenter trial the feasibility and clinical efficacy of the combination of alemtuzumab (Campath-1H) with the cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) regimen (CHOP-C) as the primary treatment for patients with peripheral T-cell lymphoma (PTCL), between January 2003 and December 2005, 24 consecutive patients with PTCL entered the study and received 8 CHOP courses. Alemtuzumab was added at 30 mg subcutaneously at day −1 initially to the first 4 courses (4 patients), and then to all 8 courses (20 patients). Complete remission (CR) was achieved in 17 (71%) patients, 1 had partial remission, and 6 had stable/progressive disease. At a median follo…

Adultmedicine.medical_specialtyVincristineAntibodies NeoplasmImmunologyKaplan-Meier EstimateCHOPAntibodies Monoclonal HumanizedBiochemistryGastroenterologyChemoimmunotherapyAntigens CDAntigens NeoplasmMulticenter trialInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansMulticenter Studies as TopicAlemtuzumabCyclophosphamideSocieties MedicalAgedGlycoproteinsDose-Response Relationship Drugbusiness.industryPralatrexateAntibodies MonoclonalLymphoma T-Cell PeripheralCell BiologyHematologyMiddle Agedmedicine.diseaseSurgeryRegimenCD52 AntigenItalyDoxorubicinVincristineAlemtuzumabPrednisonebusinessProgressive diseasemedicine.drug
researchProduct

Unruptured tubal pregnancy: local low-dose therapy with methotrexate under transvaginal ultrasonographic guidance.

1996

Thirty patients with unruptured ectopic pregnancy (4-10 weeks' gestation) were treated locally with methotrexate (MTX) under sonographic guidance. The transvaginal puncture was performed under analgesic sedation using an automatic puncturing device. Local MTX therapy was successful in 25 patients (83.3%). Eighteen of these patients had received a single MTX instillation with a total dose of 10 mg, 7 patients had received a second instillation with 10 mg because of plateauing hCG levels after the first instillation. In 5 patients MTX therapy was unsuccessful. Surgical intervention was necessary within 4 h to 15 days after MTX treatment, due to severe tubal bleeding (n = 1) or the development…

Adultmedicine.medical_specialtymedicine.drug_classAntimetaboliteChorionic Gonadotropinchemistry.chemical_compoundRoute of administrationPregnancyUnruptured tubal pregnancymedicineHumansUltrasonographyEctopic pregnancybusiness.industryLow doseObstetrics and Gynecologymedicine.diseaseSurgeryTrophoblastsMethotrexateReproductive MedicinechemistryAntifolateGestationMethotrexateFemalePregnancy Tubalbusinessmedicine.drugGynecologic and obstetric investigation
researchProduct

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission.…

2019

Abstract To assess the effectiveness of the treatment with high dosage of corticosteroids (CCSs), as first-line therapy, in inducing remission in naïve Adult-onset Still's disease (AOSD) patients compared with low dosage of CCSs, after 6 months. To further evaluate the rate of patients maintaining the remission and the rate of CCSs discontinuation, after additional 12 months of follow-up. A retrospective evaluation of patients prospectively followed was designed to compare the rate of clinical remission in naïve AOSD patients treated with high dosages of CCSs (0.8–1 mg/kg/day of prednisone-equivalent) or low dosage of CCSs (0.2–0.3 mg/kg/day of prednisone-equivalent), after 6 months. An add…

Adult-OnsetMalePediatricsAdult-onset Still's diseaseDiseaseAdrenal Cortex Hormonecorticosteroids0302 clinical medicinemonocyclic patternAdrenal Cortex HormonesRetrospective StudieMedicine030212 general & internal medicineProspective StudiesProspective cohort studyRemission InductionDisease ManagementGeneral MedicineMiddle AgedTreatment OutcomeHigh dosage030220 oncology & carcinogenesisFemaleDrugStill's Disease Adult-OnsetResearch ArticleHumanAdultcorticosteroidmedicine.medical_specialtyLow dosageObservational StudyAdult-onset Still's diseaseFollow-Up StudieDose-Response Relationship03 medical and health sciencesremissionAdult-onset Still's disease; corticosteroids; first-line therapy; monocyclic pattern; remission; Adrenal Cortex Hormones; Adult; Disease Management; Dose-Response Relationship Drug; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Retrospective Studies; Still's Disease Adult-Onset; Treatment Outcomefirst-line therapyHumansRetrospective StudiesDose-Response Relationship Drugbusiness.industry6900Retrospective cohort studyStill's DiseaseFirst line treatmentSettore MED/16 - ReumatologiaProspective StudieMethotrexateObservational studybusinessFollow-Up Studies
researchProduct

Screening of pharmacologic adulterant classes in herbal formulations using voltammetry of microparticles.

2013

A solid state electrochemical method for screening different families of adulterant chemicals illegally added to commercial phytotherapuetic formulations is described. The proposed method, based on the voltammetry of microparticles approach, permits a fast and sensitive way to distinguish between anorexics (amfepramone, fenproporex, sibutramine), benzozodiazepinic anxiolytics (clonazepam, flurazepam, alprazolam, midazolam, medazepam, chlordiazepoxide, diazepam), antidepressants (bupropione, fluoxetine, sertraline, paroxetine), diuretics (hydrochlorothiazide, furosemide, chlortalidone, amiloride, spironolactone), and hypoglycemics (glimepiride, chlorpropamide, glibenclamide) based on charact…

AdulterantChromatographyFlurazepamChemistryChemistry PharmaceuticalClinical BiochemistryAmfepramoneDrug Evaluation PreclinicalPharmaceutical ScienceElectrochemical TechniquesPharmacologyFenproporexMicrospheresAnalytical ChemistryMedazepamGlimepirideHydrochlorothiazideDrug DiscoverymedicinePlant PreparationsDrug ContaminationDiazepamSpectroscopymedicine.drugJournal of pharmaceutical and biomedical analysis
researchProduct

Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats.

2002

The hormone insulin acts in the central nervous system (CNS) as a regulator of body adiposity and food intake. Recent work from our laboratory has provided evidence that one way by which insulin may decrease food intake is by decreasing the rewarding properties of food. Evidence from others suggests that endogenous opioids may mediate the palatable properties of foods, and insulin may decrease nonfood-related reward via interaction with some CNS kappa opioid systems. In the present study we examined the ability of insulin to interact with exogenous or endogenous kappa opioids to modulate feeding of palatable sucrose pellets by nondeprived rats. Insulin (5 mU intracerebroventricular (i.c.v.)…

AgonistMaleNarcoticsmedicine.medical_specialtySucrosePhysiologymedicine.drug_classmedicine.medical_treatmentNarcotic AntagonistsBiochemistryκ-opioid receptorNaltrexoneCellular and Molecular NeuroscienceEndocrinologyInternal medicinemedicineAnimalsInsulinEndogenous opioidInjections Intraventricularbusiness.industryInsulinReceptors Opioid kappa34-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide (trans)-IsomerFeeding BehaviorNaltrexoneRatsEndocrinologyOpioidbusinessNorbinaltorphiminemedicine.drugHormonePeptides
researchProduct

Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1.

2005

The G protein coupling characteristics of a flag epitope-tagged orexin receptor type 1 (OX1R) was investigated in HEK293 cells. Immunoprecipitation of the OX1R and immunoblotting revealed interactions with Gq/G11 proteins as well as with Gs and Gi proteins. Stimulation with orexin-A did not affect the ability of the OX1R to coprecipitate Gq/G11 proteins, but it robustly elevated the intracellular concentration of Ca2+, [Ca2+]i. No changes in cAMP levels could be detected upon receptor stimulation. To get further insight into the functional correlation of G protein activation and Ca2+ signalling, we used baculovirus transduction to express chimeric G proteins, containing the Galphas protein …

AgonistReceptors Neuropeptidemedicine.drug_classG proteinBiologyKidneyBiochemistryCell LineReceptors G-Protein-CoupledGTP-binding protein regulatorsGTP-Binding ProteinsOrexin ReceptorsTransduction GeneticMuscarinic acetylcholine receptormedicineCyclic AMPHumansCalcium SignalingPharmacologyReceptor Muscarinic M3Neurotransmitter AgentsOrexinsDose-Response Relationship DrugNeuropeptidesIntracellular Signaling Peptides and ProteinsMuscarinic acetylcholine receptor M3Fusion proteinOrexin receptorCell biologyBiochemistryCalciumSignal transductionBaculoviridaeSignal TransductionBiochemical pharmacology
researchProduct

Data from: Effects of undergrowth removal and edge proximity on ground beetles and vascular plants in urban boreal forests

2019

Urban forests are regularly managed for human safety and aesthetic reasons, but they are crucial habitat for many species. Removals of undergrowth occur commonly in these forests, yet the ecological consequences of these operations are poorly understood. We sampled ground beetles (Coleoptera, Carabidae) and vascular plants along 20-m edge gradients in Finnish urban forests, in five stands treated 0.5−2.5 years earlier with undergrowth removal and in five untreated stands. We hypothesized that undergrowth removal and edge proximity would benefit opportunistic and open-habitat species, whereas shady-habitat species would be affected negatively. (1) Regarding carabids, diversity and evenness i…

Agrostis capillarisRichnessDryopteris filix-masMilium effusumNardus strictaRubus idaeusVaccinium myrtillusLeistus terminatusCarex canescensLinnaea borealisOxalis acetocellaLuzula luzuloidesParis quadrifoliaLonicera xylosteumPterostichus nigerGeranium sylvaticumCalamagrostis arundinaceusmedicine and health carePatrobus assimilisTaraxacum spFragaria vescaArtemisia vulgarisPterostichus diligensCalathus micropterusPterostichus oblongopunctatusCalathus melanocephalusPhleum pretenseDeschampsia flexuosaHypericum maculatumViola rivinianaPterostichus melanariusLife SciencesPterostichus nigritaActaea spicataUrtica dioicaMelampyrum pretenseEquisetum pretenseFestuca ovinaSorbus aucupariaRubus saxatilisAnisodactylus binotatusMedicineMelica nutansCarabidaeAmara lunicollisAnthriscus sylvestrisLuzula pilosaTrechus secalisPterostichus strenuousCarabus hortensisHarpalus tardusedge effectGalium albumVeronica officinalisBadister lacertosusAlchemilla spQuaternaryCychrus caraboidesDryopteris carthusianaMaianthemum bifoliumPatrobus atrorufusTrechus rivularisNotiophilus biguttatusGeum urbanumundergrowthVaccinium vitis-idaeaMelampyrum sylvaticumGymnocarpium dryopterisDeschampsia cespitosaLoricera pilicornisCarex acutaAmara communisRanunculus repensConvallaria majalisAthyrium filix-feminaRibes rubrumHoloceneCirsium arvensePoa chaixiiAegopodium podagrariaTrientalis europaeaLeistus ferrugineusEquisetum sylvaticumRanunculus acrisEpilobium montanumAcer platanoidesScrophularia nodosaHarpalus laevipesUrtica urensCarabus nemoralisHieracium sylvaticaCampanula rotundifoliaSynuchus vivalisEpilobium angustifoliumVeronica chamaedrys
researchProduct

Counterexamples for unique continuation

1988

AlgebraContinuationNumber theoryGeneral MathematicsAlgebraic geometryAlgorithmMathematicsCounterexampleManuscripta Mathematica
researchProduct

Changes in Body Composition in Anorexia Nervosa : Predictors of Recovery and Treatment Outcome

2015

The restoration of body composition (BC) parameters is considered to be one of the most important goals in the treatment of patients with anorexia nervosa (AN). However, little is known about differences between AN diagnostic subtypes [restricting (AN-R) and binge/purging (AN-BP)] and weekly changes in BC during refeeding treatment. Therefore, the main objectives of our study were twofold: 1) to assess the changes in BC throughout nutritional treatment in an AN sample and 2) to analyze predictors of BC changes during treatment, as well as predictors of treatment outcome. The whole sample comprised 261 participants [118 adult females with AN (70 AN-R vs. 48 AN-BP), and 143 healthy controls].…

Anorexia Nervosa:Psychiatry and Psychology::Mental Disorders::Eating Disorders::Binge-Eating Disorder [Medical Subject Headings]Body water:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]lcsh:MedicineÍndice de masa corporalAnorexia nervosaMetabolismo basal:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]FatsImpedancia eléctricaadolescentslcsh:Science:Psychiatry and Psychology::Mental Disorders::Eating Disorders::Anorexia Nervosa [Medical Subject Headings]eating-disordersBody mass indexMetasMultidisciplinaryBulimia nervosaFemeninoAnorèxia nerviosaTrastorno por atracónModelos logísticos:Anatomy::Tissues::Connective Tissue::Adipose Tissue [Medical Subject Headings]HumanosTreatment OutcomeBasal metabolic rate measurementfat distributionbioelectrical-impedanceBody CompositionEating disordersObesitatFemalewomenmedicine.symptomBioelectrical impedance analysisResearch ArticleAdultTejido adiposomedicine.medical_specialtyPatient Dropoutsweight-gainwaterPes corporal:Anatomy::Fluids and Secretions::Body Fluids::Body Water [Medical Subject Headings]Anorexia nerviosa:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Motivation::Goals [Medical Subject Headings]Internal medicine:Health Care::Health Care Quality Access and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome [Medical Subject Headings]medicineTreatment guidelinesHumansObesityComposición corporal:Health Care::Health Care Quality Access and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Models Statistical::Logistic Models [Medical Subject Headings]Trastorns de la conducta alimentàriabusiness.industrylcsh:Renergy-expenditureduration:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques Endocrine::Thyroid Function Tests::Basal Metabolism [Medical Subject Headings]:Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Body Composition [Medical Subject Headings]Anorexia nervosaBody weightmedicine.diseaseObesityAgua corporalEndocrinology:Check Tags::Female [Medical Subject Headings]Bulimia nervosaCase-Control StudiesBasal metabolic ratelcsh:QResultado del tratamiento:Phenomena and Processes::Physical Phenomena::Magnetic Phenomena::Electromagnetic Phenomena::Electricity::Electric Conductivity::Electric Impedance [Medical Subject Headings]businessBody mass indexWeight gain
researchProduct